Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk

Abstract
Registry-based epidemiologic studies suggest associations between chronic inflammatory intestinal diseases and pancreatic ductal adenocarcinoma (PDAC). As genetic susceptibility contributes to a large proportion of chronic inflammatory intestinal diseases, we hypothesize that the genomic regions surrounding established genome-wide associated variants for these chronic inflammatory diseases are associated with PDAC. We examined the association between PDAC and genomic regions (+/- 500 kb) surrounding established common susceptibility variants for ulcerative colitis, Crohn's disease, inflammatory bowel disease, celiac disease, chronic pancreatitis, and primary sclerosing cholangitis. We analyzed summary statistics from genome-wide association studies data for 8,384 cases and 11,955 controls of European descent from two large consortium studies using the summary data-based adaptive rank truncated product method to examine the overall association of combined genomic regions for each inflammatory disease group. Combined genomic susceptibility regions for ulcerative colitis, Crohn's disease, inflammatory bowel disease, and chronic pancreatitis were associated with PDAC at P-values < 0.05 (0.0040, 0.0057, 0.011, and 3.4 × 10-6, respectively). After excluding the 20 PDAC susceptibility regions (+/- 500 kb) previously identified by GWAS, the genomic regions for ulcerative colitis, Crohn's disease, and inflammatory bowel disease remained associated with PDAC (P-values = 0.0029, 0.0057, and 0.0098, respectively). Genomic regions for celiac disease (P-value = 0.22) and primary sclerosing cholangitis (P-value = 0.078) were not associated with PDAC. Our results support the hypothesis that genomic regions surrounding variants associated with inflammatory intestinal diseases, particularly, ulcerative colitis, Crohn's disease, inflammatory bowel disease, and chronic pancreatitis are associated with PDAC.
Funding Information
  • Division of Cancer Epidemiology and Genetics
  • NCI
  • NIH (R03 CA123546-02)
  • Ministry of Health of the Czech Republic (NR 9029-4/2006, NR9422-3, NR9998-3, MH CZ-DRO-MMCI 00209805)
  • NCI (P50CA062924, R01CA97075, P30 CA006973)
  • Lustgarten Foundation
  • Sol Goldman Pancreas Cancer Research Center (RO1 CA154823, HHSN261200800001E)
  • Mayo Clinic SPORE in Pancreatic Cancer (P50 CA102701, P30CA008748)
  • National Health and Medical Research Council of Australia (442302)
  • NHMRC Senior Research Fellowship (#1060183)
  • NIH
  • NCI (R01CA1009767, R01CA109767-S1, R01CA059706)
  • California Department of Public Health
  • NCI (HSN261201000140C)
  • CDC's National Program of Cancer Registries (#U58DP003862-01)
  • California Department of Public Health
  • NCI
  • NIH (5R01CA098870)
  • Czech Science Foundation (P301/12/1734)
  • Internal Grant Agency of the Czech Ministry of Health (IGA NT 13 263)
  • Heidelberger EPZ-Pancobank
  • BMBF (01GS08114)
  • BMBH
  • BMBF (01EY1101)
  • Italian Ministry of Health (RC1203GA57, RC1303GA53, RC1303GA54, RC1303GA50)
  • Italian Association for Research on Cancer
  • Italian Ministry of Research (AIRC n. 12182)
  • Italian FIMP-Ministry of Health
  • National Institute for Health Research Liverpool Pancreas Biomedical Research Unit, UK
  • NCI
  • VicHealth and Cancer Council Victoria (209057, 396414, 1074383)
  • Cancer Council Victoria
  • NYU Women's Health Study
  • NIH (UM1 CA182934, P30 CA016087, P30 ES000260)
  • Instituto de Salud Carlos III-FEDER, Spain
  • Fondo de Investigaciones Sanitarias (#PI13/00082, #PI15/01573)
  • Red Temática de Investigación Cooperativa en Cáncer, Spain (#RD12/0036/0050)
  • European Cooperation in Science and Technology (#BM1204)
  • Ministerio de Ciencia y Tecnología (2000-0097)
  • Fondo de Investigación Sanitaria (95/0017)
  • Madrid, Spain; Generalitat de Catalunya
  • ‘Red temática de investigación cooperativa de centros en Cáncer’ (C03/10)
  • ‘Red temática de investigación cooperativa de centros en Epidemiología y salud pública’ (C03/09)
  • CIBER de Epidemiología
  • CIBERESP (CA-097193, CA-34944, CA-40360, HL-26490, HL-34595)
  • NIH
  • Women's Health Study (CA-047988, CA-182913, HL-043851, HL-080467, HL-099355)
  • NIH
  • NIH (UM1 CA167552)
  • NCI
  • NIH (UM1 CA186107, P01 CA87969, R01 CA49449)
  • NIH (CA63464, CA54281, CA098758, CA132839, CA164973)
  • NCI
  • Hale Center for Pancreatic Cancer Research (U01 CA21017)
  • NCI
  • United States Department of Defense (CA130288)
  • Lustgarten Foundation
  • Pancreatic Cancer Action Network
  • Noble Effort Fund
  • Peter R. Leavitt Family Fund
  • Wexler Family Fund
  • Broman Family Fund for Pancreatic Cancer Research
  • Bob Parsons Fellowship (K07 CA222159)
  • National Heart, Lung, and Blood Institute
  • NIH
  • U.S. Department of Health and Human Services (HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C)
  • NCI
  • NIH (U10 CA37429, UM1 CA182883)
  • NIH
  • NCI
  • NHGRI
  • NHLBI
  • NIDA
  • NIMH
  • NINDS